Finding the right diabetic neuropathy pain treatment can be challenging when a well-chosen first medication provides only partial relief. Burning, shooting pain, tingling, and allodynia can continue to disrupt sleep, mobility, mood, and daily function. Fortunately, clinicians do not always have to choose between abandoning a partially effective drug and …
Read More »Why Are We Ignoring the Gold Standard for Healing Diabetic Foot Ulcers?
Diabetic foot ulcer offloading is one of the most important parts of treating a neuropathic plantar ulcer, yet the most effective approaches are still not routinely used. Non-removable knee-high devices, including total contact casts and non-removable walkers, can reduce damaging pressure while supporting wound healing. So why does a treatment …
Read More »The Return of Aldose Reductase Inhibitors: Could an Old Idea Finally Pay Off?
Diabetes care has advanced dramatically over the past decade. While therapies such as GLP-1 receptor agonists and SGLT2 inhibitors have transformed glucose management and cardiovascular outcomes, many patients continue to develop long-term complications. Could an older therapeutic target finally provide the missing piece? Interest in aldose reductase inhibitors for diabetes …
Read More »Could We Predict Diabetic Neuropathy Years Before Symptoms Begin?
Early detection has always been one of the biggest challenges in diabetes care. What if doctors could identify patients at high risk for diabetic neuropathy or kidney disease years before symptoms developed? That possibility is driving exciting new research into IgG glycosylation in diabetes, an emerging area that examines subtle …
Read More »Could Hearing Loss Be an Early Warning Sign of Future Diabetes Complications?
For many people living with diabetes, complications such as retinopathy, nephropathy, and neuropathy are well-recognized concerns. However, growing evidence suggests that hearing loss may deserve a place on that list as well. Researchers are increasingly examining whether hearing loss reflects the same vascular and neurologic damage that contributes to complications …
Read More »Constipation, Bloating, and Diabetes: Could Autonomic Neuropathy Be the Cause?
Many people with diabetes expect complications such as retinopathy, kidney disease, or peripheral neuropathy. However, gastrointestinal symptoms often receive far less attention despite their significant impact on quality of life. Chronic constipation, bloating, abdominal discomfort, and irregular bowel habits affect a substantial number of individuals living with diabetes. In many …
Read More »The Diabetes Complication Patients Rarely Mention: Understanding Urinary Incontinence
Urinary incontinence is one of the most common yet least discussed complications of diabetes. In fact, diabetes urinary incontinence affects people with diabetes at significantly higher rates than the general population. While healthcare professionals routinely monitor patients for retinopathy, nephropathy, and cardiovascular disease, bladder dysfunction often remains overlooked. However, research …
Read More »Diabetes and Hearing Loss: The Complication Many Clinicians Still Miss
Diabetes-related complications often bring to mind kidney disease, neuropathy, or vision problems. However, one complication continues to receive far less attention despite growing scientific concern: hearing loss linked to diabetes. Emerging evidence suggests that people with diabetes may face a significantly higher risk of hearing decline, yet routine auditory screening …
Read More »GLP-1s and Microvascular Complications: Do They Change Neuropathy Trajectory?
Cardiovascular outcomes often dominate discussions about GLP-1 receptor agonists, but what about nerve health? Growing interest in GLP-1 diabetic neuropathy reflects a broader shift toward understanding microvascular complications beyond heart disease. While medications such as semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza) have proven cardiovascular benefits, their potential influence on …
Read More »GLP-1s and Chronic Pain: Anti-Inflammatory Effect or Weight-Driven Relief?
Patients using GLP-1 receptor agonists are reporting something unexpected: less joint and musculoskeletal pain. As interest grows in how GLP-1 therapies may affect chronic pain, clinicians are asking an important question. Are these improvements simply the result of weight loss, or do GLP-1 medications have direct anti-inflammatory and neuromodulatory effects? …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.